Design, Synthesis and Biological Activity of Novel Antitumor Drugs, 2nd Edition
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 April 2026) | Viewed by 986
Special Issue Editors
Interests: design, synthesis and biological characterization of pharmacologically actives small molecules, peptidomimetics e peptides (antitumoral agents, antiviral compounds and ionic channel modulators); study of new reaction mechanisms and synthetic strategy optimization
Special Issues, Collections and Topics in MDPI journals
Interests: novel target; anticancer; small molecules; biological evaluation; synthesis; activity assay; molecular modeling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Anticancer therapy represents an open challenge in the research field due to off-target toxicity and the development of chemoresistance phenomena. The recent advances in molecular biology have opened the way for the recognition of novel molecular targets that previously have not been explored and analyzed for cancer treatment. In this context, a design that is supported by molecular modeling methodologies, synthesis, and the pharmacological characterization of small molecules active against these new targets plays a key role in the medicinal chemistry field, representing a focal point for the future development of more effective treatments.
Dr. Alessia Bertamino
Dr. Tania Ciaglia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- novel target
- anticancer
- small molecules
- biological evaluation
- synthesis
- activity assay
- molecular modeling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
